Ileal neuroendocrine tumor G1

MONDO:0006250

A well differentiated, low grade neuroendocrine tumor (carcinoid tumor) that arises from the ileum. The mitotic count is less than 2 per 10 HPF and/or the Ki67 index is equal to or less than 2 percent.

Also known as: carcinoid tumor of ileum, carcinoid tumor of the ileum, carcinoid tumour of ileum, carcinoid tumour of the ileum, grade 1 neuroendocrine neoplasm of ileum, ileal NET G1, ileal carcinoid tumor, ileal carcinoid tumour

1498 clinical trials for this condition and its sub-types, 3 tagged with Ileal neuroendocrine tumor G1 itself.

Follow this condition to get notified about new trials

Where it sits in the disease tree

Browse by category →

Part of

↑ Small intestinal neuroendocrine tumor G1 (5) ↑ Colon neuroendocrine tumor G1 (3) ↑ Ileal neuroendocrine tumor, well differentiated, low or intermediate grade (3)

Including sub-types (1498) Tagged with Ileal neuroendocrine tumor G1 (3)

Trials to join now! 2 Completed 1

New pill could ease carcinoid syndrome Flare-Ups

Symptom relief Completed

This Phase 2 trial tested paltusotine, an oral drug, in 36 adults with carcinoid syndrome. The study looked at safety and how the body processes the drug at different doses. Participants were randomly assigned to 40 mg or 80 mg daily, with dose adjustments allowed. The goal is to…

Phase 2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Symptom relief

Last updated Jun 27, 2026 11:02 UTC

Ileal neuroendocrine tumor G1

Where it sits in the disease tree

New pill could ease carcinoid syndrome Flare-Ups